Table 3 Comparison according to the management decision reflecting the clinical severity
From: COVID-19 pandemic: CT chest in COVID-19 infection and prediction of patient’s ICU needs
Variables | ICU (N = 54) | Hospital (N = 70) | Home (N = 216) | P value | |
|---|---|---|---|---|---|
Mean age (years) | 55.2 ± 15.3 a | 51.7 ± 14.5 a | 41.7 ± 13.4 b | ^ 0.001 * | |
Sex | Male | 34 (63.0%) | 44 (62.9%) | 134 (62.0%) | # 0.987 |
Female | 20 (37.0%) | 26 (37.1%) | 82 (38.0%) | ||
Initial negative PCR | 0 (0.0%) a | 13 (18.6%) b | 36 (16.7%) b | # 0.004 * | |
Severity score | 14.5 ± 6.1 a | 9.8 ± 5.2 b | 5.7 ± 3.7 c | ^ < 0.001* | |
CT probability | High | 33 (61.1%) a | 55 (78.6%) a | 149 (69.0%) a | # 0.001 * |
Intermediate | 11 (20.4%) a | 4 (5.7%) b | 26 (12.0%) ab | ||
Low | 10 (18.5%) a | 10 (14.3%) a | 17 (7.9%) a | ||
Negative | 0 (0.0%) a | 1 (1.4%) a | 24 (11.1%) b | ||
GGO (ground-glass opacity) | 44 (81.5%) | 61 (87.1%) | 187 (86.6%) | # 0.595 | |
GGO rounded | 10 (22.7%) a | 25 (41.0%) a | 127 (67.9%) b | # < 0.001 * | |
GGO linear | 17 (38.6%) a | 17 (27.9%) ab | 31 (16.6%) b | # 0.003 * | |
GGO patchy | 10 (22.7%) | 8 (13.1%) | 31 (16.6%) | # 0.426 | |
GGO confluence | 5 (11.4%) ab | 14 (23.0%) a | 20 (10.7%) b | # 0.046 * | |
GGO diffuse | 3 (6.8%) a | 0 (0.0%) b | 0 (0.0%) b | § 0.003 * | |
GGO laterality | Unilateral | 3 (6.8%) | 5 (8.2%) | 27 (14.4%) | # 0.222 |
Bilateral | 41 (93.2%) | 56 (91.8%) | 160 (85.6%) | ||
GGO location | Peripheral | 36 (81.8%) a | 59 (96.7%) b | 176 (94.1%) ab | § 0.014 * |
Central | 8 (18.2%) | 2 (3.3%) | 11 (5.9%) | ||
GGO lobar affection | Multilobar | 43 (97.7%) | 58 (95.1%) | 170 (90.9%) | # 0.249 |
Unilobar | 1 (2.3%) | 3 (4.9%) | 17 (9.1%) | ||
Crazy paving | 30 (55.6%) ab | 42 (60.0%) a | 82 (38.0%) b | # 0.001 * | |
Vascular enlargement | 17 (31.5%) | 18 (25.7%) | 65 (30.1%) | # 0.733 | |
Consolidation | 44 (81.5%) a | 25 (35.7%) b | 29 (13.4%) c | # < 0.001 * | |
Consolidation type | Lobar | 17 (38.6%) a | 7 (28.0%) a | 1 (3.4%) b | # 0.003 * |
Segmental/subsegmental | 27 (61.4%) | 18 (72.0%) | 28 (96.6%) | ||
Consolidation > GG | 36 (66.7%) a | 10 (14.3%) b | 6 (2.8%) c | # < 0.001 * | |
Curvilinear opacity | 12 (22.2%) | 20 (28.6%) | 58 (26.9%) | # 0.713 | |
Pleural effusion | 23 (42.6%) a | 11 (15.7%) b | 4 (1.9%) c | # < 0.001 * | |
Fibrosis | 4 (7.4%) | 3 (4.3%) | 10 (4.6%) | § 0.632 | |
LN (lymphadenopathy) | 2 (3.7%) | 4 (5.7%) | 5 (2.3%) | § 0.290 | |
Nodules | 3 (5.6%) | 3 (4.3%) | 5 (2.3%) | § 0.324 | |
Bronchiectasis | 4 (7.4%) a | 0 (0.0%) b | 4 (1.9%) b | § 0.028 * | |
Cavitation | 0 (0.0%) | 0 (0.0%) | 1 (0.5%) | § 1.000 | |